Anders Westanmo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anders Westanmo has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Bilal
Division of Gastroenterology and Hepatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA
4 shared publications - Alexander K. Tsai
Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Center for Immunology, University of Minnesota, Minneapolis, MN 55455, USA
2 shared publications - Amy Gravely
Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota
2 shared publications - Amy Ma Gravely
Research Service, Minneapolis VA Health Care System, 1 Veterans Dr., Minneapolis, MN 55417, USA
2 shared publications - Anne Hudson Blaes
Masonic Cancer Center University of Minnesota Minneapolis Minnesota USA
2 shared publications - Arjun Gupta
City of Hope Cancer Center, Phoenix, AZ
2 shared publications
Latest Publications
- 23 June 2026
- Published byĀ American College of PhysiciansĀ inĀ Annals of Internal Medicine
- Vol.Ā 179 Ā (9) , 1363-1365
Outpatient Antibiotic Prescribing for Uncomplicated Diverticulitis in Veterans Affairs Facilities: A Retrospective Cohort Study
- 23 June 2026
- Published byĀ American College of PhysiciansĀ inĀ Annals of Internal Medicine
- Vol.Ā 179 Ā (9) , 1363-1365
Outpatient Antibiotic Prescribing for Uncomplicated Diverticulitis in Veterans Affairs Facilities: A Retrospective Cohort Study
- Open Access
- 9 March 2026
- Published byĀ MDPI AGĀ inĀ Journal of Clinical & Translational Ophthalmology
- Vol.Ā 4 Ā (1) , 7
Omega-3 Fatty Acid Supplementation and Incident Age-Related Macular Degeneration in a United States Veteran Population: A Retrospective Cohort Study
Background: Higher intake of omega-3 fatty acids from food sources is associated with a reduced risk of age-related macular degeneration (AMD), but there are no recommended parameters for omega-3 fatty acid supplementation. The purpose of our study was to investigate whether fish oil supplementation protects against development of AMD in the US Veteran Affairs (VA) Corporate Data Warehouse. Methods: Patients ā„ 55 years without an AMD diagnosis at the initial eye examination who also had a 5-year follow up eye examination were included in this retrospective cohort study. Patients receiving fish oil supplementation from the VA pharmacy were categorized into the fish oil exposure group and matched 1:1 to a non-exposure control group. All patients were assessed for AMD development at the 5-year follow up eye examination. Results: AMD developed in 772 of 16,172 patients (4.8%) with fish oil exposure and 635 of 16,093 (3.9%) without fish oil exposure (relative risk (RR) = 1.21, 95% confidence interval (CI) = 1.09ā1.34, p = 0.0003). Compared to controls, AMD risk was similar in low-dose (RR = 0.91; 95% CI = 0.65ā1.27) and moderate-dose (RR = 0.93; 95% CI = 0.79ā1.10) fish oil supplementation but higher in high-dose fish oil supplementation (RR = 1.32; 95% CI = 1.19ā1.47). Conclusions: Fish oil supplementation did not protect against AMD in a US veteran population.
- 9 March 2026
- Published byĀ MDPI AGĀ inĀ Journal of Clinical & Translational Ophthalmology
- Vol.Ā 4 Ā (1) , 7
Open AccessOmega-3 Fatty Acid Supplementation and Incident Age-Related Macular Degeneration in a United States Veteran Population: A Retrospective Cohort Study
Background: Higher intake of omega-3 fatty acids from food sources is associated with a reduced risk of age-related macular degeneration (AMD), but there are no recommended parameters for omega-3 fatty acid supplementation. The purpose of our study was to investigate whether fish oil supplementation protects against development of AMD in the US Veteran Affairs (VA) Corporate Data Warehouse. Methods: Patients ā„ 55 years without an AMD diagnosis at the initial eye examination who also had a 5-year follow up eye examination were included in this retrospective cohort study. Patients receiving fish oil supplementation from the VA pharmacy were categorized into the fish oil exposure group and matched 1:1 to a non-exposure control group. All patients were assessed for AMD development at the 5-year follow up eye examination. Results: AMD developed in 772 of 16,172 patients (4.8%) with fish oil exposure and 635 of 16,093 (3.9%) without fish oil exposure (relative risk (RR) = 1.21, 95% confidence interval (CI) = 1.09ā1.34, p = 0.0003). Compared to controls, AMD risk was similar in low-dose (RR = 0.91; 95% CI = 0.65ā1.27) and moderate-dose (RR = 0.93; 95% CI = 0.79ā1.10) fish oil supplementation but higher in high-dose fish oil supplementation (RR = 1.32; 95% CI = 1.19ā1.47). Conclusions: Fish oil supplementation did not protect against AMD in a US veteran population.
- 7 July 2025
- Published byĀ Wolters Kluwer HealthĀ inĀ American Journal of Gastroenterology
- Vol.Ā 121 Ā (3) , 776-784
Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test-Positive Individuals: Prevalence, Predictors, and Root Cause Analysis in a Nationwide Cohort
INTRODUCTION: Postcolonoscopy colorectal cancer (PCCRC) represents an important real-world colonoscopy quality indicator. Using a national database, we evaluated predictors of PCCRC in fecal immunochemical test (FIT)-positive individuals, determined the PCCRC 3-year (PCCRC-3y) rate, and performed a root cause analysis (RCA). METHODS: This retrospective cohort study evaluated FIT-positive patients who underwent colonoscopy from January 2015 to July 2022. Data were collected from the Veterans Affairs national database. PCCRC was defined as CRC detected ā„6 months after colonoscopy. CRC was identified using Systematized Nomenclature of Medicine codes and the Veterans Affairs Cancer Registry. The World Endoscopy Organization methodology was used to perform the RCA and calculate the PCCRC-3y rate. RESULTS: We identified 132 PCCRCs among 52,167 FIT-positive individuals. The PCCRC-3y rate was 6.4% (95% confidence interval [CI] 5.0%ā7.7%). PCCRC locations were proximal colon (43.2%), distal colon (34.8%), and rectum (22%). Root causes were likely new CRC (17.4%), missed lesions with adequate (31.2%) or inadequate (9.8%) examination, incomplete polyp resection (22%), and detected but unresected lesions (19.7%). 16.7% of patients with PCCRC had poor bowel preparation on index colonoscopy. The cecal intubation rate was 88.6%, and rectal retroflexion rate was 84.5%. In 14.4% of cases, recommended surveillance intervals did not adhere to established guidelines. Independent predictors of PCCRC were ages 70ā79 years (hazard ratio [HR] 7.86; 95% CI 1.08ā57.39), age ā„80 years (HR 10.18; 95% CI 1.06ā97.98), tubulovillous adenoma (HR 3.98; 95% CI 2.52ā6.29), and adenoma with high-grade dysplasia (HR 10.15; 95% CI 5.91ā17.42). DISCUSSION: Among FIT-positive individuals, the PCCRC-3y rate was 6.4%, with missed lesions and incomplete resection as key contributors. These findings provide useful information on quality metrics in FIT-based CRC-screening programs.
- 7 July 2025
- Published byĀ Wolters Kluwer HealthĀ inĀ American Journal of Gastroenterology
- Vol.Ā 121 Ā (3) , 776-784
Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test-Positive Individuals: Prevalence, Predictors, and Root Cause Analysis in a Nationwide Cohort
INTRODUCTION: Postcolonoscopy colorectal cancer (PCCRC) represents an important real-world colonoscopy quality indicator. Using a national database, we evaluated predictors of PCCRC in fecal immunochemical test (FIT)-positive individuals, determined the PCCRC 3-year (PCCRC-3y) rate, and performed a root cause analysis (RCA). METHODS: This retrospective cohort study evaluated FIT-positive patients who underwent colonoscopy from January 2015 to July 2022. Data were collected from the Veterans Affairs national database. PCCRC was defined as CRC detected ā„6 months after colonoscopy. CRC was identified using Systematized Nomenclature of Medicine codes and the Veterans Affairs Cancer Registry. The World Endoscopy Organization methodology was used to perform the RCA and calculate the PCCRC-3y rate. RESULTS: We identified 132 PCCRCs among 52,167 FIT-positive individuals. The PCCRC-3y rate was 6.4% (95% confidence interval [CI] 5.0%ā7.7%). PCCRC locations were proximal colon (43.2%), distal colon (34.8%), and rectum (22%). Root causes were likely new CRC (17.4%), missed lesions with adequate (31.2%) or inadequate (9.8%) examination, incomplete polyp resection (22%), and detected but unresected lesions (19.7%). 16.7% of patients with PCCRC had poor bowel preparation on index colonoscopy. The cecal intubation rate was 88.6%, and rectal retroflexion rate was 84.5%. In 14.4% of cases, recommended surveillance intervals did not adhere to established guidelines. Independent predictors of PCCRC were ages 70ā79 years (hazard ratio [HR] 7.86; 95% CI 1.08ā57.39), age ā„80 years (HR 10.18; 95% CI 1.06ā97.98), tubulovillous adenoma (HR 3.98; 95% CI 2.52ā6.29), and adenoma with high-grade dysplasia (HR 10.15; 95% CI 5.91ā17.42). DISCUSSION: Among FIT-positive individuals, the PCCRC-3y rate was 6.4%, with missed lesions and incomplete resection as key contributors. These findings provide useful information on quality metrics in FIT-based CRC-screening programs.
- 17 July 2024
- Published byĀ Wolters Kluwer HealthĀ inĀ American Journal of Gastroenterology
- Vol.Ā 120 Ā (3) , 554-561
Glucagon-Like Peptide Receptor Agonists Use Before Endoscopy Is Associated With Low Retained Gastric Contents: A Multicenter Cross-Sectional Analysis
INTRODUCTION: While ubiquity of glucagon-like peptide receptor agonists (GLP1-RAs) is rising, guidance from the gastroenterology societies and American Society of Anesthesiologist (ASA) remains in conflict on recommendations regarding preoperative holding before endoscopy. The aim of this study was to address this by evaluating the effect of GLP1-RAs on gastric retention during upper endoscopy. METHODS: This multicenter cross-sectional study included patients on confirmed GLP1-RAs receiving an endoscopy from 2021 to 2023. Demographics, prescribing practices, and procedure outcomes were captured. GLP1-RA management of preoperative holding was retroactively classified per ASA guidance. Multivariable logistic regression was performed to assess factors influencing retained gastric contents. RESULTS: Of 815 patients, 70 (8.7%) had retained gastric contents on endoscopy of whom 65 (93%) had type 2 diabetes mellitus. Only 1 (1.4%) of these patients required unplanned intubation, and none had aspiration events. Those with GLP1-RA held per ASA guidance (406, 49.8%) were less likely to have retained contents (4.4% vs 12.7%, P < 0.001), but there were no significant differences to intubation (0% vs 2%, P = 0.53) or aborting procedure rates (28% vs 18%, P = 0.40) due to gastric retention. On multivariable analysis, likelihood of food retention increased 36% (95% confidence interval 1.15ā1.60) for every 1% increase in hemoglobin A1C after adjusting for GLP1-RA type and preoperative medication hold. DISCUSSION: In this multicenter study, very low rates of retained gastric contents were seen during endoscopy in patients on GLP1-RAs and most were in patients with type 2 diabetes mellitus. Our findings suggest an individualized approach rather than universal preoperative holding of medications before endoscopy.
- 17 July 2024
- Published byĀ Wolters Kluwer HealthĀ inĀ American Journal of Gastroenterology
- Vol.Ā 120 Ā (3) , 554-561
Glucagon-Like Peptide Receptor Agonists Use Before Endoscopy Is Associated With Low Retained Gastric Contents: A Multicenter Cross-Sectional Analysis
INTRODUCTION: While ubiquity of glucagon-like peptide receptor agonists (GLP1-RAs) is rising, guidance from the gastroenterology societies and American Society of Anesthesiologist (ASA) remains in conflict on recommendations regarding preoperative holding before endoscopy. The aim of this study was to address this by evaluating the effect of GLP1-RAs on gastric retention during upper endoscopy. METHODS: This multicenter cross-sectional study included patients on confirmed GLP1-RAs receiving an endoscopy from 2021 to 2023. Demographics, prescribing practices, and procedure outcomes were captured. GLP1-RA management of preoperative holding was retroactively classified per ASA guidance. Multivariable logistic regression was performed to assess factors influencing retained gastric contents. RESULTS: Of 815 patients, 70 (8.7%) had retained gastric contents on endoscopy of whom 65 (93%) had type 2 diabetes mellitus. Only 1 (1.4%) of these patients required unplanned intubation, and none had aspiration events. Those with GLP1-RA held per ASA guidance (406, 49.8%) were less likely to have retained contents (4.4% vs 12.7%, P < 0.001), but there were no significant differences to intubation (0% vs 2%, P = 0.53) or aborting procedure rates (28% vs 18%, P = 0.40) due to gastric retention. On multivariable analysis, likelihood of food retention increased 36% (95% confidence interval 1.15ā1.60) for every 1% increase in hemoglobin A1C after adjusting for GLP1-RA type and preoperative medication hold. DISCUSSION: In this multicenter study, very low rates of retained gastric contents were seen during endoscopy in patients on GLP1-RAs and most were in patients with type 2 diabetes mellitus. Our findings suggest an individualized approach rather than universal preoperative holding of medications before endoscopy.
- 11 December 2023
- Published byĀ ElsevierĀ inĀ Gastrointestinal Endoscopy
- Vol.Ā 99 Ā (6) , 971-980.e1
Outcomes of cold snare EMR of nonampullary duodenal adenomas ā„1 cm: a multicenter study
- 11 December 2023
- Published byĀ ElsevierĀ inĀ Gastrointestinal Endoscopy
- Vol.Ā 99 Ā (6) , 971-980.e1
Outcomes of cold snare EMR of nonampullary duodenal adenomas ā„1 cm: a multicenter study
- Open Access
- 30 November 2023
- Published byĀ The Korean Society of Gastrointestinal EndoscopyĀ inĀ Clinical Endoscopy
- Vol.Ā 56 Ā (6) , 790-794
Outcomes of endoscopic retrograde cholangiopancreatography in patients with situs inversus viscerum
Background/Aims: Situs inversus viscerum (SIV) is a congenital condition defined by left-to-right transposition of all visceral organs. This anatomical variant has caused technical challenges in endoscopic retrograde cholangiopancreatography (ERCP). Data on ERCP in patients with SIV are limited to case reports of unknown clinical and technical success rates. This study aimed to evaluate the clinical and technical success rates of ERCP in patients with SIV.Methods: Data from patients with SIV who underwent ERCP were retrospectively reviewed. The data were collected by querying the nationwide Veterans Affairs Health System database for patients diagnosed with SIV who underwent ERCP. Patient demographics and procedural characteristics were collected.Results: Eight patients with SIV who underwent ERCP were included. Choledocholithiasis was the most common indication for ERCP (62.5%). The technical success rate was 63%. Subsequent ERCP with interventional radiologyāassisted rendezvous has increased the technical success rate to 100%. Clinical success was achieved in 63% of cases. Among cases of subsequent rendezvous ERCP after conventional ERCP failure, clinical success was achieved in 100%.Conclusions: The clinical and technical success rates of ERCP in patients with SIV were both 63%. In patients with SIV in whom ERCP fails, interventional radiologyāassisted rendezvous ERCP can be considered.
- 30 November 2023
- Published byĀ The Korean Society of Gastrointestinal EndoscopyĀ inĀ Clinical Endoscopy
- Vol.Ā 56 Ā (6) , 790-794
Open AccessOutcomes of endoscopic retrograde cholangiopancreatography in patients with situs inversus viscerum
Background/Aims: Situs inversus viscerum (SIV) is a congenital condition defined by left-to-right transposition of all visceral organs. This anatomical variant has caused technical challenges in endoscopic retrograde cholangiopancreatography (ERCP). Data on ERCP in patients with SIV are limited to case reports of unknown clinical and technical success rates. This study aimed to evaluate the clinical and technical success rates of ERCP in patients with SIV.Methods: Data from patients with SIV who underwent ERCP were retrospectively reviewed. The data were collected by querying the nationwide Veterans Affairs Health System database for patients diagnosed with SIV who underwent ERCP. Patient demographics and procedural characteristics were collected.Results: Eight patients with SIV who underwent ERCP were included. Choledocholithiasis was the most common indication for ERCP (62.5%). The technical success rate was 63%. Subsequent ERCP with interventional radiologyāassisted rendezvous has increased the technical success rate to 100%. Clinical success was achieved in 63% of cases. Among cases of subsequent rendezvous ERCP after conventional ERCP failure, clinical success was achieved in 100%.Conclusions: The clinical and technical success rates of ERCP in patients with SIV were both 63%. In patients with SIV in whom ERCP fails, interventional radiologyāassisted rendezvous ERCP can be considered.
- 1 November 2023
- Published byĀ American Society of Clinical Oncology (ASCO)Ā inĀ JCO Oncology Practice
- Vol.Ā 19 Ā (11_suppl) , 477
Healthcare contact days experienced by patients with advanced gastrointestinal cancer.
- 1 November 2023
- Published byĀ American Society of Clinical Oncology (ASCO)Ā inĀ JCO Oncology Practice
- Vol.Ā 19 Ā (11_suppl) , 477
Healthcare contact days experienced by patients with advanced gastrointestinal cancer.
- 1 November 2023
- Published byĀ American Society of Clinical Oncology (ASCO)Ā inĀ JCO Oncology Practice
- Vol.Ā 19 Ā (11) , 1031-1038
Health Care Contact Days Experienced by Decedents With Advanced GI Cancer
Patients with stage IV GI cancer spent 1 in 4 days alive with health care contact!
- 1 November 2023
- Published byĀ American Society of Clinical Oncology (ASCO)Ā inĀ JCO Oncology Practice
- Vol.Ā 19 Ā (11) , 1031-1038
Health Care Contact Days Experienced by Decedents With Advanced GI Cancer
Patients with stage IV GI cancer spent 1 in 4 days alive with health care contact!
- 1 May 2023
- Published byĀ Wolters Kluwer HealthĀ inĀ Journal of Psychiatric Practice
- Vol.Ā 29 Ā (3) , 202-212
Antidepressant Strategies for Treatment of Acute Depressive Episodes Among Veterans
Objective: The 2016 VA/DoD Clinical Practice Guideline for Management of Major Depressive Disorder offers consensus-based recommendations when response to the initial antidepressant medication is suboptimal; however, little is known about āreal-worldā pharmacological strategies used by providers treating depression in the Veterans Affairs Health Care System (VAHCS). Methods: We extracted pharmacy and administrative records of patients diagnosed with a depressive disorder and treated at the Minneapolis VAHCS between January 1, 2010 and May 11, 2021. Patients with bipolar disorder, psychosis-spectrum, or dementia diagnoses were excluded. An algorithm was developed to identify antidepressant strategies: monotherapy (MONO); optimization (OPM); switching (SWT); combination (COM); and augmentation (AUG). Additional data extracted included demographics, service utilization, other psychiatric diagnoses, and clinical risk for hospitalization and mortality. Results: The sample consisted of 1298 patients, 11.3% of whom were female. The mean age of the sample was 51 years. Half of the patients received MONO, with 40% of those patients receiving inadequate doses. OPM was the most common next-step strategy. SWT and COM/AUG were used for 15.9% and 2.6% of patients, respectively. Overall, patients who received COM/AUG were younger. OPM, SWT, and COM/AUG occurred more frequently in psychiatric services settings and required a greater number of outpatient visits. The association between antidepressant strategies and risk of mortality became nonsignificant after accounting for age. Conclusions: Most of the veterans with acute depression were treated with a single antidepressant, while COM and AUG were rarely used. The age of the patient, and not necessarily greater medical risks, appeared to be a major factor in decisions about antidepressant strategies. Future studies should evaluate whether implementation of underutilized COM and AUG strategies early in the course of depression treatment are feasible.
- 1 May 2023
- Published byĀ Wolters Kluwer HealthĀ inĀ Journal of Psychiatric Practice
- Vol.Ā 29 Ā (3) , 202-212
Antidepressant Strategies for Treatment of Acute Depressive Episodes Among Veterans
Objective: The 2016 VA/DoD Clinical Practice Guideline for Management of Major Depressive Disorder offers consensus-based recommendations when response to the initial antidepressant medication is suboptimal; however, little is known about āreal-worldā pharmacological strategies used by providers treating depression in the Veterans Affairs Health Care System (VAHCS). Methods: We extracted pharmacy and administrative records of patients diagnosed with a depressive disorder and treated at the Minneapolis VAHCS between January 1, 2010 and May 11, 2021. Patients with bipolar disorder, psychosis-spectrum, or dementia diagnoses were excluded. An algorithm was developed to identify antidepressant strategies: monotherapy (MONO); optimization (OPM); switching (SWT); combination (COM); and augmentation (AUG). Additional data extracted included demographics, service utilization, other psychiatric diagnoses, and clinical risk for hospitalization and mortality. Results: The sample consisted of 1298 patients, 11.3% of whom were female. The mean age of the sample was 51 years. Half of the patients received MONO, with 40% of those patients receiving inadequate doses. OPM was the most common next-step strategy. SWT and COM/AUG were used for 15.9% and 2.6% of patients, respectively. Overall, patients who received COM/AUG were younger. OPM, SWT, and COM/AUG occurred more frequently in psychiatric services settings and required a greater number of outpatient visits. The association between antidepressant strategies and risk of mortality became nonsignificant after accounting for age. Conclusions: Most of the veterans with acute depression were treated with a single antidepressant, while COM and AUG were rarely used. The age of the patient, and not necessarily greater medical risks, appeared to be a major factor in decisions about antidepressant strategies. Future studies should evaluate whether implementation of underutilized COM and AUG strategies early in the course of depression treatment are feasible.
- Open Access
Breast Cancer and Women Veterans: What Is the Impact of Mental Health on Screening Rates?
Background: The proportion of women Veterans are increasing and, as such, access to high-quality breast cancer care is important. Prior studies have shown that rural location, age, and a mental health diagnosis negatively impact breast cancer screening rates. Methods: We aimed to retrospectively assess the impact of these risk factors on breast cancer screening adherence rates among Veterans at our institution. Women who were eligible for breast cancer screening per the United States Preventative Services Taskforce guidelines were included. Results: Of 2321 women, overall adherence was 78.2%. There were no significant differences in screening rates between races, various age groups, geographical distribution, and having anxiety or post-traumatic stress disorder (PTSD). However, Veterans with a diagnosis of depression were more likely to adhere to screening guidelines. Having multiple mental health diagnoses was also not a negative risk factor. Conclusions: Our Veteran populationās adherence rates are higher than the national average and rural location, race, age, and certain mental health disorders did not negatively affect adherence to screening mammography. Though more research is needed, screening reminders from our womenās health coordinator may have improved adherence rates and lowered disparities.
Open AccessBreast Cancer and Women Veterans: What Is the Impact of Mental Health on Screening Rates?
Background: The proportion of women Veterans are increasing and, as such, access to high-quality breast cancer care is important. Prior studies have shown that rural location, age, and a mental health diagnosis negatively impact breast cancer screening rates. Methods: We aimed to retrospectively assess the impact of these risk factors on breast cancer screening adherence rates among Veterans at our institution. Women who were eligible for breast cancer screening per the United States Preventative Services Taskforce guidelines were included. Results: Of 2321 women, overall adherence was 78.2%. There were no significant differences in screening rates between races, various age groups, geographical distribution, and having anxiety or post-traumatic stress disorder (PTSD). However, Veterans with a diagnosis of depression were more likely to adhere to screening guidelines. Having multiple mental health diagnoses was also not a negative risk factor. Conclusions: Our Veteran populationās adherence rates are higher than the national average and rural location, race, age, and certain mental health disorders did not negatively affect adherence to screening mammography. Though more research is needed, screening reminders from our womenās health coordinator may have improved adherence rates and lowered disparities.